Form D · Biotechnology
Alercell Inc
Bozeman, Us, MT · CIK 0002160842
Offering snapshot reported Oct 19, 2026 · SEC filing
- Reported sold
- $35K Offering amount: $1.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Oct 12, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 19, 2026 | Initial | $35,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601737
Source: Form D, filed Oct 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frederic George Etienne Scheer | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5 West Mendenhall Suite 202
Bozeman, Us, MT, 59715
Phone: 4069208787
Bozeman, Us, MT, 59715
Phone: 4069208787